Additionally, it is established that participants with IEIs can have a higher frequency of viral persistence and prolonged COVID-19 compared to controls and may in part explain the durability of anti-S IgG, IgA, and IgM at D3 + 24wk (47, 48). The gene discussed is CD79A; the disease is COVID-19.